Request Sample Inquiry
Gene Synthesis Market

Gene Synthesis Market

Gene Synthesis Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

179

Base Year:

2023

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1259

Segments Covered
  • By Product By Product Short mers single-stranded oligos (ssDNA), Linear double-stranded gene fragments (dsDNA), Circular Clonal Plasmids
  • By Technology By Technology Polymerase Chain Reaction (PCR), Oligonucleotide Synthesis, Gene Assembly, Site-directed mutagenesis
  • By End User By End User Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organisations
  • By Applications By Applications Research & Development, Diagnostics, Therapeutics, Others
  • By Services By Services Gene Synthesis Service, GMP Gene Synthesis, Gene Fragments Service, Others
  • By Final Usage By Final Usage Nucleic Acid Based Vaccines, Cell and Gene Therapies, Protein/mAb Engineering, Genome Programming
  • By Region By Region North America, Europe, Asia Pacific, Latin America, The Middle-East and Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2030
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 1,904.1 Million
Revenue 2030Revenue 2030: USD 5,805.8 Million
Revenue CAGRRevenue CAGR (2024 - 2030): 17.26%
Fastest Growing Region Fastest Growing Region (2024 - 2030) Europe
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Gene Synthesis Market - Segment Analysis
    1. Overview
    2. Global Gene Synthesis Market, 2016 - 2028 (USD Million)
    3. Global Gene Synthesis Market - by Product
      1. By Short mers single-stranded oligos (ssDNA)
      2. By Linear double-stranded gene fragments (dsDNA)
      3. By Circular Clonal Plasmids
    4. Global Gene Synthesis Market - by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Oligonucleotide Synthesis
      3. By Gene Assembly
      4. By Site-directed mutagenesis
    5. Global Gene Synthesis Market - by End User
      1. By Academic and Research Institutes
      2. By Pharmaceutical Companies
      3. By Biotechnology Companies
      4. By Contract Research Organisations
    6. Global Gene Synthesis Market - by Applications
      1. By Research & Development
      2. By Diagnostics
      3. By Therapeutics
      4. By Others
    7. Global Gene Synthesis Market - by Services
      1. By Gene Synthesis Service
      2. By GMP Gene Synthesis
      3. By Gene Fragments Service
      4. By Others
    8. Global Gene Synthesis Market - by Final Usage
      1. By Nucleic Acid Based Vaccines
      2. By Cell and Gene Therapies
      3. By Protein/mAb Engineering
      4. By Genome Programming
    9. Global Gene Synthesis Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    10. Market comparative analysis
  4. North America Gene Synthesis Market - Segment Analysis
    1. Overview
    2. North America Gene Synthesis Market, 2016 - 2028 (USD Million)
    3. North America Gene Synthesis Market, by Product
      1. By Short mers single-stranded oligos (ssDNA)
      2. By Linear double-stranded gene fragments (dsDNA)
      3. By Circular Clonal Plasmids
    4. North America Gene Synthesis Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Oligonucleotide Synthesis
      3. By Gene Assembly
      4. By Site-directed mutagenesis
    5. North America Gene Synthesis Market, by End User
      1. By Academic and Research Institutes
      2. By Pharmaceutical Companies
      3. By Biotechnology Companies
      4. By Contract Research Organisations
    6. North America Gene Synthesis Market, by Applications
      1. By Research & Development
      2. By Diagnostics
      3. By Therapeutics
      4. By Others
    7. North America Gene Synthesis Market, by Services
      1. By Gene Synthesis Service
      2. By GMP Gene Synthesis
      3. By Gene Fragments Service
      4. By Others
    8. North America Gene Synthesis Market, by Final Usage
      1. By Nucleic Acid Based Vaccines
      2. By Cell and Gene Therapies
      3. By Protein/mAb Engineering
      4. By Genome Programming
    9. North America Gene Synthesis Market, by Country
      1. U.S.
        1. U.S. Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. U.S. Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. U.S. Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. U.S. Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. U.S. Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. U.S. Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      2. Canada
        1. Canada Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Canada Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Canada Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Canada Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Canada Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Canada Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      3. Mexico
        1. Mexico Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Mexico Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Mexico Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Mexico Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Mexico Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Mexico Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
  5. Europe Gene Synthesis Market - Segment Analysis
    1. Overview
    2. Europe Gene Synthesis Market, 2016 - 2028 (USD Million)
    3. Europe Gene Synthesis Market, by Product
      1. By Short mers single-stranded oligos (ssDNA)
      2. By Linear double-stranded gene fragments (dsDNA)
      3. By Circular Clonal Plasmids
    4. Europe Gene Synthesis Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Oligonucleotide Synthesis
      3. By Gene Assembly
      4. By Site-directed mutagenesis
    5. Europe Gene Synthesis Market, by End User
      1. By Academic and Research Institutes
      2. By Pharmaceutical Companies
      3. By Biotechnology Companies
      4. By Contract Research Organisations
    6. Europe Gene Synthesis Market, by Applications
      1. By Research & Development
      2. By Diagnostics
      3. By Therapeutics
      4. By Others
    7. Europe Gene Synthesis Market, by Services
      1. By Gene Synthesis Service
      2. By GMP Gene Synthesis
      3. By Gene Fragments Service
      4. By Others
    8. Europe Gene Synthesis Market, by Final Usage
      1. By Nucleic Acid Based Vaccines
      2. By Cell and Gene Therapies
      3. By Protein/mAb Engineering
      4. By Genome Programming
    9. Europe Gene Synthesis Market, by Country
      1. Germany
        1. Germany Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Germany Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Germany Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Germany Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Germany Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Germany Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      2. UK
        1. UK Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. UK Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. UK Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. UK Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. UK Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. UK Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      3. France
        1. France Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. France Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. France Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. France Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. France Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. France Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      4. Spain
        1. Spain Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Spain Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Spain Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Spain Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Spain Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Spain Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      5. Italy
        1. Italy Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Italy Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Italy Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Italy Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Italy Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Italy Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      6. BENELUX
        1. BENELUX Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. BENELUX Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. BENELUX Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. BENELUX Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. BENELUX Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. BENELUX Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      7. Rest of Europe
        1. Rest Of Europe Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Rest Of Europe Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Rest Of Europe Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Rest Of Europe Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Rest Of Europe Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Rest Of Europe Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
  6. Asia Pacific Gene Synthesis Market - Segment Analysis
    1. Overview
    2. Asia Pacific Gene Synthesis Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Gene Synthesis Market, by Product
      1. By Short mers single-stranded oligos (ssDNA)
      2. By Linear double-stranded gene fragments (dsDNA)
      3. By Circular Clonal Plasmids
    4. Asia Pacific Gene Synthesis Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Oligonucleotide Synthesis
      3. By Gene Assembly
      4. By Site-directed mutagenesis
    5. Asia Pacific Gene Synthesis Market, by End User
      1. By Academic and Research Institutes
      2. By Pharmaceutical Companies
      3. By Biotechnology Companies
      4. By Contract Research Organisations
    6. Asia Pacific Gene Synthesis Market, by Applications
      1. By Research & Development
      2. By Diagnostics
      3. By Therapeutics
      4. By Others
    7. Asia Pacific Gene Synthesis Market, by Services
      1. By Gene Synthesis Service
      2. By GMP Gene Synthesis
      3. By Gene Fragments Service
      4. By Others
    8. Asia Pacific Gene Synthesis Market, by Final Usage
      1. By Nucleic Acid Based Vaccines
      2. By Cell and Gene Therapies
      3. By Protein/mAb Engineering
      4. By Genome Programming
    9. Asia Pacific Gene Synthesis Market, by Country
      1. China
        1. China Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. China Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. China Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. China Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. China Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. China Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      2. Japan
        1. Japan Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Japan Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Japan Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Japan Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Japan Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Japan Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      3. India
        1. India Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. India Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. India Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. India Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. India Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. India Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      4. South Korea
        1. South Korea Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. South Korea Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. South Korea Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. South Korea Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. South Korea Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. South Korea Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      5. South East Asia
        1. South East Asia Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. South East Asia Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. South East Asia Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. South East Asia Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. South East Asia Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. South East Asia Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Rest of Asia Pacific Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Rest of Asia Pacific Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Rest of Asia Pacific Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Rest of Asia Pacific Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Rest of Asia Pacific Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
  7. Latin America Gene Synthesis Market - Segment Analysis
    1. Overview
    2. Latin America Gene Synthesis Market, 2016 - 2028 (USD Million)
    3. Latin America Gene Synthesis Market, by Product
      1. By Short mers single-stranded oligos (ssDNA)
      2. By Linear double-stranded gene fragments (dsDNA)
      3. By Circular Clonal Plasmids
    4. Latin America Gene Synthesis Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Oligonucleotide Synthesis
      3. By Gene Assembly
      4. By Site-directed mutagenesis
    5. Latin America Gene Synthesis Market, by End User
      1. By Academic and Research Institutes
      2. By Pharmaceutical Companies
      3. By Biotechnology Companies
      4. By Contract Research Organisations
    6. Latin America Gene Synthesis Market, by Applications
      1. By Research & Development
      2. By Diagnostics
      3. By Therapeutics
      4. By Others
    7. Latin America Gene Synthesis Market, by Services
      1. By Gene Synthesis Service
      2. By GMP Gene Synthesis
      3. By Gene Fragments Service
      4. By Others
    8. Latin America Gene Synthesis Market, by Final Usage
      1. By Nucleic Acid Based Vaccines
      2. By Cell and Gene Therapies
      3. By Protein/mAb Engineering
      4. By Genome Programming
    9. Latin America Gene Synthesis Market, by Country
      1. Brazil
        1. Brazil Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Brazil Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Brazil Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Brazil Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Brazil Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Brazil Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      2. Argentina
        1. Argentina Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Argentina Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Argentina Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Argentina Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Argentina Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Argentina Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      3. Rest of Latin America
        1. Rest of Latin America Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Rest of Latin America Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Rest of Latin America Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Rest of Latin America Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Rest of Latin America Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Rest of Latin America Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
  8. Middle East & Africa Gene Synthesis Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Gene Synthesis Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Gene Synthesis Market, by Product
      1. By Short mers single-stranded oligos (ssDNA)
      2. By Linear double-stranded gene fragments (dsDNA)
      3. By Circular Clonal Plasmids
    4. Middle East & Africa Gene Synthesis Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Oligonucleotide Synthesis
      3. By Gene Assembly
      4. By Site-directed mutagenesis
    5. Middle East & Africa Gene Synthesis Market, by End User
      1. By Academic and Research Institutes
      2. By Pharmaceutical Companies
      3. By Biotechnology Companies
      4. By Contract Research Organisations
    6. Middle East & Africa Gene Synthesis Market, by Applications
      1. By Research & Development
      2. By Diagnostics
      3. By Therapeutics
      4. By Others
    7. Middle East & Africa Gene Synthesis Market, by Services
      1. By Gene Synthesis Service
      2. By GMP Gene Synthesis
      3. By Gene Fragments Service
      4. By Others
    8. Middle East & Africa Gene Synthesis Market, by Final Usage
      1. By Nucleic Acid Based Vaccines
      2. By Cell and Gene Therapies
      3. By Protein/mAb Engineering
      4. By Genome Programming
    9. Middle East & Africa Gene Synthesis Market, by Country
      1. GCC Countries
        1. GCC Countries Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. GCC Countries Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. GCC Countries Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. GCC Countries Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. GCC Countries Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. GCC Countries Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      2. South Africa
        1. South Africa Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. South Africa Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. South Africa Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. South Africa Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. South Africa Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. South Africa Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Gene Synthesis Market, By Product
          1. By Short mers single-stranded oligos (ssDNA)
          2. By Linear double-stranded gene fragments (dsDNA)
          3. By Circular Clonal Plasmids
        2. Rest of Middle East & Africa Gene Synthesis Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Oligonucleotide Synthesis
          3. By Gene Assembly
          4. By Site-directed mutagenesis
        3. Rest of Middle East & Africa Gene Synthesis Market, By End User
          1. By Academic and Research Institutes
          2. By Pharmaceutical Companies
          3. By Biotechnology Companies
          4. By Contract Research Organisations
        4. Rest of Middle East & Africa Gene Synthesis Market, By Applications
          1. By Research & Development
          2. By Diagnostics
          3. By Therapeutics
          4. By Others
        5. Rest of Middle East & Africa Gene Synthesis Market, By Services
          1. By Gene Synthesis Service
          2. By GMP Gene Synthesis
          3. By Gene Fragments Service
          4. By Others
        6. Rest of Middle East & Africa Gene Synthesis Market, By Final Usage
          1. By Nucleic Acid Based Vaccines
          2. By Cell and Gene Therapies
          3. By Protein/mAb Engineering
          4. By Genome Programming
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. THERMO FISHER SCIENTIFIC INC.
    2. GENSCRIPT
    3. INTEGRATED DNA TECHNOLOGIES INC.
    4. ORIGENE TECHNOLOGIES INC.
    5. BIOMATIK
    6. TWIST BIOSCIENCE
    7. BROOKS AUTOMATION INC.
    8. BOSTER BIOLOGICAL TECHNOLOGY
    9. PROTEOGENIX INC.
    10. PROMAB BIOTECHNOLOGIES INC.
    11. MERCK KGAA
    12. EUROFINS GENOMICS
    13. BIO BASIC INC.
    14. Gene Universal Inc.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 17-Feb-2022
Gene Synthesis Market to Reach Valuation of USD 6.58 Billion by 2028 - Rising Prevalence of Infectious Diseases as well as Chronic Diseases is Driving the Market
FAQ
Frequently Asked Question

  • The global Gene Synthesis valued at USD 1,904.1 Million in 2023 and is expected to reach USD 5,805.8 Million in 2030 growing at a CAGR of 17.26%.

  • The prominent players in the market are THERMO FISHER SCIENTIFIC INC., GENSCRIPT, INTEGRATED DNA TECHNOLOGIES INC., ORIGENE TECHNOLOGIES INC., BIOMATIK, TWIST BIOSCIENCE, BROOKS AUTOMATION INC., BOSTER BIOLOGICAL TECHNOLOGY, PROTEOGENIX INC., PROMAB BIOTECHNOLOGIES INC., MERCK KGAA, EUROFINS GENOMICS, BIO BASIC INC., Gene Universal Inc..

  • The market is project to grow at a CAGR of 17.26% between 2024 and 2030.

  • The driving factors of the Gene Synthesis include

    • Growing Demand for Customized DNA Sequences

  • North America was the leading regional segment of the Gene Synthesis in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy